Market Overview:
The global in vitro diagnostics (IVD) quality control product market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for quality control products, quality assurance services, and data management solutions in the IVD industry. Additionally, the increasing incidence of diseases and rising awareness about early diagnosis are also contributing to the growth of this market. On the basis of type, the global IVD quality control product market is segmented into quality control products, quality assurance services, and data management solutions. The quality control products segment is further divided into reagents & kits, instruments & systems, software & services. The reagents & kits segment accounted for majority share of this market in 2017 owing to their wide use in various applications such as clinical chemistry, immunochemistry,, hematology molecular diagnostics,, and others). On the basis of application,.immunochemistry,.hematology.,immunochemistry,,hematology.
 Quality Control Product Industry Outlook.svg)
Product Definition:
In vitro diagnostics (IVD) quality control product is a material used to test the accuracy and reliability of in vitro diagnostic devices. The importance of IVD quality control product is that it ensures that patients are accurately diagnosed, which can lead to more effective treatment.
Quality Control Products:
Quality control products are the set of tools used to monitor and control the process of making a product. It includes instruments, reagents, kits & assays that help in ensuring that every batch is made with high quality. The factors such as growing demand for IVD devices globally and increasing R&D activities related to these devices are expected to drive market growth over the forecast period.
Quality Assurance Services:
Quality assurance services are performed to provide a quality product. It is an umbrella term for activities performed by companies that manufacture IVD devices to ensure the device meets their own internal standards as well as those set by regulatory agencies.
The IVD QC market is segmented into two types on the basis of service.
Application Insights:
The clinical chemistry segment dominated the global market in terms of revenue share in 2017. This is due to a large number of tests that are performed using blood samples for diagnosis. The hematology and molecular diagnostics segments also had significant market share owing to increasing demand for rapid, accurate, and sensitive diagnostic methods across the globe. Increasing prevalence of chronic diseases such as cancer, diabetes mellitus, autoimmune disorders & cardiovascular disease is expected to boost product adoption over the forecast period.
Infectious diseases testing accounted for a major share in 2017 owing to an increase in prevalence of infectious diseases such as HIV/AIDS across all regions coupled with an increase focus on early diagnosis resulting into increased R&D activities pertaining these infections which will eventually result into advanced testing techniques which will fuel growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies and well-established healthcare infrastructure. Moreover, increasing demand for point-of-care (PoC) diagnostics is anticipated to drive growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising government initiatives for improving healthcare facilities coupled with an increase in disposable income and standard of living resulting into a rise in consumer awareness about early diagnosis leading into demand for IVD testing products & services. Furthermore, growing investments by key market players are projected to fuel regional growth over the next eight years (2018– 2030).
Growth Factors:
- Increasing demand for quality control products in the IVD market
- Growing number of regulatory approvals for IVD quality control products
- Rising demand from emerging markets
- Technological advancements in the field of IVD quality control products
- Growing awareness about the benefits of using quality control products in the IVD market
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Diagnostics (IVD) Quality Control Product Market Research Report
By Type
Quality Control Products, Quality Assurance Services, Data Management Solutions
By Application
Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Others
By Companies
Bio-Rad Laboratories, Thermo Fisher Scientific, Randox Laboratories, Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Technopath Clinical Diagnostics, Sun Diagnostics, Zeptometrix Corporation, ISOLAB, Sysmex Corporation, Fortress Diagnostics, Meril Life Sciences, Multiplicom, Future Diagnostics Solutions, Surmodics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Diagnostics (IVD) Quality Control Product Market Report Segments:
The global In Vitro Diagnostics (IVD) Quality Control Product market is segmented on the basis of:
Types
Quality Control Products, Quality Assurance Services, Data Management Solutions
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Randox Laboratories
- Roche Diagnostics
- Abbott Diagnostics
- Helena Laboratories
- Seracare Life Sciences
- Technopath Clinical Diagnostics
- Sun Diagnostics
- Zeptometrix Corporation
- ISOLAB
- Sysmex Corporation
- Fortress Diagnostics
- Meril Life Sciences
- Multiplicom
- Future Diagnostics Solutions
- Surmodics
 Quality Control Product Market Overview.svg)
Highlights of The In Vitro Diagnostics (IVD) Quality Control Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Quality Control Products
- Quality Assurance Services
- Data Management Solutions
- By Application:
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Diagnostics (IVD) Quality Control Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Quality Control Product Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In Vitro Diagnostics (IVD) quality control product is a system that helps to ensure the accuracy and reliability of diagnostic tests.
Some of the major companies in the in vitro diagnostics (ivd) quality control product market are Bio-Rad Laboratories, Thermo Fisher Scientific, Randox Laboratories, Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Technopath Clinical Diagnostics, Sun Diagnostics, Zeptometrix Corporation, ISOLAB, Sysmex Corporation, Fortress Diagnostics, Meril Life Sciences, Multiplicom, Future Diagnostics Solutions, Surmodics.
The in vitro diagnostics (ivd) quality control product market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro Diagnostics (IVD) Quality Control Product Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Vitro Diagnostics (IVD) Quality Control Product Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Vitro Diagnostics (IVD) Quality Control Product Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Vitro Diagnostics (IVD) Quality Control Product Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Vitro Diagnostics (IVD) Quality Control Product Market Size & Forecast, 2018-2028
4.5.1 In Vitro Diagnostics (IVD) Quality Control Product Market Size and Y-o-Y Growth
4.5.2 In Vitro Diagnostics (IVD) Quality Control Product Market Absolute $ Opportunity
Chapter 5 Global In Vitro Diagnostics (IVD) Quality Control Product Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Type
5.2.1 Quality Control Products
5.2.2 Quality Assurance Services
5.2.3 Data Management Solutions
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Vitro Diagnostics (IVD) Quality Control Product Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Applications
6.2.1 Clinical Chemistry
6.2.2 Immunochemistry
6.2.3 Hematology
6.2.4 Molecular Diagnostics
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro Diagnostics (IVD) Quality Control Product Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Vitro Diagnostics (IVD) Quality Control Product Analysis and Forecast
9.1 Introduction
9.2 North America In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Type
9.6.1 Quality Control Products
9.6.2 Quality Assurance Services
9.6.3 Data Management Solutions
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Applications
9.10.1 Clinical Chemistry
9.10.2 Immunochemistry
9.10.3 Hematology
9.10.4 Molecular Diagnostics
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Vitro Diagnostics (IVD) Quality Control Product Analysis and Forecast
10.1 Introduction
10.2 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Type
10.6.1 Quality Control Products
10.6.2 Quality Assurance Services
10.6.3 Data Management Solutions
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Applications
10.10.1 Clinical Chemistry
10.10.2 Immunochemistry
10.10.3 Hematology
10.10.4 Molecular Diagnostics
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Product Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Type
11.6.1 Quality Control Products
11.6.2 Quality Assurance Services
11.6.3 Data Management Solutions
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Applications
11.10.1 Clinical Chemistry
11.10.2 Immunochemistry
11.10.3 Hematology
11.10.4 Molecular Diagnostics
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Vitro Diagnostics (IVD) Quality Control Product Analysis and Forecast
12.1 Introduction
12.2 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Type
12.6.1 Quality Control Products
12.6.2 Quality Assurance Services
12.6.3 Data Management Solutions
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Applications
12.10.1 Clinical Chemistry
12.10.2 Immunochemistry
12.10.3 Hematology
12.10.4 Molecular Diagnostics
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Product Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Type
13.6.1 Quality Control Products
13.6.2 Quality Assurance Services
13.6.3 Data Management Solutions
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Vitro Diagnostics (IVD) Quality Control Product Market Size Forecast by Applications
13.10.1 Clinical Chemistry
13.10.2 Immunochemistry
13.10.3 Hematology
13.10.4 Molecular Diagnostics
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro Diagnostics (IVD) Quality Control Product Market: Competitive Dashboard
14.2 Global In Vitro Diagnostics (IVD) Quality Control Product Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 Thermo Fisher Scientific
14.3.3 Randox Laboratories
14.3.4 Roche Diagnostics
14.3.5 Abbott Diagnostics
14.3.6 Helena Laboratories
14.3.7 Seracare Life Sciences
14.3.8 Technopath Clinical Diagnostics
14.3.9 Sun Diagnostics
14.3.10 Zeptometrix Corporation
14.3.11 ISOLAB
14.3.12 Sysmex Corporation
14.3.13 Fortress Diagnostics
14.3.14 Meril Life Sciences
14.3.15 Multiplicom
14.3.16 Future Diagnostics Solutions
14.3.17 Surmodics
